KESHO

Treatment of Lung Cancer with EGFR Mutations
2023-07-13 18:30 - 21:00 (Africa/Nairobi)
SPEAKER PROFILES:

Prof Shahin Sayed
Shahin Sayed is Associate Professor & Consultant in Anatomical Pathology and Cytology, in the Department of Pathology, Medical College, Aga Khan University and the current Chair and Laboratory Director of Pathology at AKUH, Nairobi.
Dr Sayed graduated from the University of Nairobi with a Bachelor of Medicine and Surgery degree. She holds a Master of Medicine in General Pathology from the University of Nairobi where she was awarded the best student in Pathology prize. She is a Fellow of the Royal College of Pathologists, United Kingdom and a Fellow of the College of Pathologists of East Central and Southern Africa.
Dr. Sayed is the Secretary General of the College of Pathologists of East Central and Southern Africa, Chair of the Academic Committee of the Senate – East Central and Southern African (ECSA) College of Health Sciences, Chair of theBoard of Directors of African Strategies for Advancing Pathology (ASAP, co-chair Technical Working Group (TWG) on Diagnostics for the Cancer Control Programme – Ministry of Health, Kenya (MoH).
She is also a steering committee member and Commissioner for the Lancet Commission on Diagnostics and a member of the Lancet Oncology Commission for Sub-Saharan Africa. She has also been a recent member of the WHO-SAGE IVD Committee (2019-2020). Dr. Sayed is a member of the United States and Canadian Academy of Pathology (USCAP) and the American Society of Clinical Oncology (ASCO).
Dr. Sayed is in charge of the breast service at AKUHN. Her research interest span oncopathology with a special focus in breast cancer and solid haematolymphoid malignancies. She has several grants and peer reviewed publications in her area of research interest. She has also led research initiatives and interventions that have developed a sustainable model of community-based engagement to improve breast cancer screening and diagnosis.
Dr Andrew Odhiambo
Andrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.
He is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP, ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals.
Dr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness.
His key areas of sub specialization and interest include Colon cancer, Stomach cancer, Breast Cancer, Pancreatic, Liver & Bile Duct cancer, Cancer or Unknown Primary, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Skin, Lung, Kidney cancers etc. For his full profile, please visit www.drandrewodhiambo.com
Prof Mohsen Mokhtar
Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.
Prof Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.
Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.
Dr Njoki Njiraini (Moderator)
Njoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital.
She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.
Dr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi, a Master’s Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.

Gallery

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Immunotherapy options for the treatment of NSCLC
2023-06-22 19:00 - 20:30
SPEAKER PROFILES:

Dr Manel Haj Mansour
Manel Haj Mansour is a Consultant Physician and board certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:

A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.

A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.

A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.

She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Naftali Busakhala (Moderator)
Naftali Busakhala is a Senior Lecturer and specialist Physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.
He is also a Senior Research Fellow at the Institute of Prevention and Research, Lyon France. He has published widely in peer reviewed journals.
Dr Busakhala is the Chairperson of the Kenya Society of Haematology and Oncology (KESHO).
He holds a Bachelor of Medicine and Surgery from Moi University and a Masters of Medicine in Internal Medicine from University of Nairobi. He also received post graduate training in Pharmacology from Tianjin University China and Makerere University Uganda. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management of Relapsed/Refractory DLBCL
2023-06-15 18:00 - 21:00
OUTLINE

The DLBCL Patient Journey: a series of patient cases, highlighting key moments where decisions made affect the outcomes for those patients.
Treating Relapsed/Refractory DLBCL in 2023: Patient Outcomes: The latest updates in treatment of Relapsed/Refractory DLBCL. What do the guidelines say in 2023? What does the future hold? The role played by cost in treatment decisions for DLBCL patients
Bone Marrow Transplant in refractory lymphoma. Is this an option in our setting?

SPEAKER PROFILES:
Prof Malkit Riyat
Malkit Riyat is an Associate Professor in Haematology and Consultant Haematologist, he completed his MBChB from the University of Nairobi in 1978. He was awarded a World Health Organization (WHO) scholarship and went on to do his membership in haematology from The Royal Infirmary, Glasgow in 1987. He was appointed as a Fellow of the Royal College of Pathologists in Haematology in 1997. He was Conferred fellowship of the College of Pathologists East Central and Southern Africa in 2014. He obtained a Certificate of Competence in Malignant Lymphomas (CCL) in 2017 – 2018 from University of ULM, Germany.
Prof. Riyat has authored multiple publications in peer review journals as well as many abstracts and has served on the editorial board of multiple peer review journals. He has been instrumental in graduate medical education, developing the curricula for the clinical pathology residency program and served as the first program director when the residency was initially initiated at the Aga Khan University Hospital in Nairobi. In 2002 he successfully implemented and coordinated the GIPAP program in Kenya through which patients with CML, GIST and several other disorders get free access to glivec.
Areas of Interest

Malignant Lymphomas
Multiple Myeloma
Low grade lymphoproliferative disorders (CLL, follicular lymphomas, Mantle Zone lymphomas etc)
Chronic myeloid leukemia (CML)
Myeloproliferative neoplasms / Myelodysplastic syndromes (PRV, ET, PMF, CMML)
Deficiency anaemias
Sickle cell disease
Thrombotic and Hemostatic disorders

Dr Douglas Nyandika
Douglas Nyandika is a Senior Registrar in Internal Medicine at the Nairobi Hospital, and is currently a fellow in Medical Oncology at the University of Nairobi.
He holds a bachelor’s degree and master’s in Internal Medicine from the University of Nairobi.
His current interests are in both hematologic malignancies especially lymphomas and leukaemia’s. In the area of solid tumours, he is interested in cancers of the breast, GI cancers and lung cancers with integration of novel therapies in their management.
Dr Nyandika is fascinated by African writers like Chimamanda Ngozi, Akwaeke Emezi and Jennifer Nansubuga. Inspired by spiritual books by Paulo Coelho, Michael Singer, and Eckhart Tolle.

Dr Rohini Radia
Rohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005.
During her haematology training and work as a consultant, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation, including 10 years at consultant level at The Russell Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023, she returned home and started as BMT Consultant at the The Nairobi West Hospital.
Her BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol, GVHD prophylaxis and post-transplant management of immune suppression, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials.
Prof Nicholas Othieno-Abinya (Moderator)
Nicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi, Kenya, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital, Nairobi. In 2009 and 2010 he was Head of Oncology at Aga Khan University Hospital, Nairobi.
He holds a Master’s degree in Internal Medicine of the University of Nairobi, completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992, and is a Fellow of the Royal College of Physicians of Edinburgh.
His research interests are in malignant haematology and breast cancer, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019.
Dr. Othieno-Abinya is a member of American Society of Clinical Oncology (ASCO), and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC), having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO), of which he was the first Chair, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine,’ Varsity Focus’ of September 2017.
Dr Wangulu Collins (Co-Moderator)
Wangulu Collins is a Consultant General Pathologist and Lecturer at the Department of Human Pathology, School of Medicine, Jomo Kenyatta University of Agriculture & Technology (JKUAT).
He holds an undergraduate degree in Medicine & Surgery, a Master’s Degree in Public Health (MPH) and Masters of Medicine (Human Pathology).
Dr Wangulu currently practice as a General Pathologist at the JKUAT Medical School Teaching Hospitals (Thika Level 5 Hospital & Mama Lucy Kibaki Hospital) and consult for private hospitals in Nairobi, Kenya. Career interests; Research, Teaching and Clinical Practice.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

CME Photos

Palliative Care and Survivorship
2023-06-08 19:00 - 20:30
Dr Joyfrida Chepchumba
Joyfrida Chepchumba is currently the Program Officer in charge of Treatment, Palliative Care, and Survivorship Pillar at the National Cancer Control Program. She coordinates all activities pertaining to cancer treatment, including partnering with health experts in both public and private sector to develop policies and guidelines to inform best practice in cancer treatment. She has coordinated development of several health policies related to cancer management including the first Kenyan Palliative Care Policy. Other policy documents under development include the National Radiotherapy protocols and Rehabilitation guidelines for children with cancer. She also oversees the M-saratani mobile platform, an e-learning platform which hosts content on early diagnosis of cancer targeting primary healthcare workers in the country. She has been working with the Ministry of Health, Kenya for over 10 years in the public health system.
She is a pharmacist with a Master’s degree in Health Economics and Policy and a Bachelor Degree in Pharmacy both from the University of Nairobi.
Dr Chepchumba previously worked at the National Quality Control Laboratory for seven years as a senior analyst where she oversaw ensuring quality of medicines and medical products through standardized analytical procedures. She is an active member of the Pharmaceutical Society of Kenya (PSK) the umbrella body for all pharmacists in Kenya.
She has submitted abstracts to different local and international conferences including the World Cancer Congress (2022), Kenya Society of Hematology and Oncology (2022), Oncology Nurses Chapter (2022) PSK (2015).
She is passionate about collaborations in developing robust heath systems to improve the quality of life for patients in the oncology space.
Dr John Weru
John Weru is an assistant Professor in Pain & Palliative Medicine at the Aga Khan University Hospital. He chairs the Hospital Ethics Committee at the institution and leads the East African Steering Committee in Palliative Care (EAPCSC) within the Aga Khan Health Services. He is the chair of the board of the Kenya Hospices and Palliative Care Association( KEHPCA). He is a faculty member with the ECHO-PACA II and the CK-BTI projects.
He is a peer reviewer with the Journal of Supportive Care in Cancer and sub-editor of the Palliative Medicine and Hospice Care Open journal. He has published peer reviewed articles and written multiple book chapters. He is the local PI for a multinational study ” ECHO Telementoring to Improve Quality of Palliative Care in Zambia, Kenya, Nigeria, Ghana, South Africa, and India.
Lilian Obetto
Lilian is the CEO of Retailpay; a retail solution-oriented technology platform, and a cancer warrior, who believes that cancer does not define who she is and her quality of life after trans versing the cancer journey for well over a decade.
Back in 2011 she had lumps on her breast and upon visiting a gynecologist, she was misdiagnosed. In 2012. the lumps were bigger, she had the first successful surgery, a lumpectomy. In mid-2017, there were metastases to the Femur bones and Nodes to the lungs, Lilian had a surgery where she had a rod implant on her left hips; this was after she had done sessions of Radiotherapy, chemotherapy, thereafter oral tablets, and Complex Chemotherapy which unfortunately, Lilian could not afford to the end.
In May 2020, Lilian started experiencing tremors in her hand and she suffered a mild stroke, the cancer had spread to Lilian’s brain. In November 2021 her mobility was compromised, leading to a brain surgery done in March 2022, thereafter Bone brain craniotomy in February 2023.
Lilian visits and encourages other cancer warriors including children with cancer; she is grateful to The Rotary who play a key role in these activities. Lilian advocates for better cancer management to the government. In November 2019 when she was graciously invited to speak where the current head of state then Deputy President was the guest of Honor- to this end there were changes made upon her request to The Head of state.
n March 2021 she initiated a cancer awareness talk in Nyakach, where 40 people attended. She shares her journey on her first book called Unbowed- How God rescued me from different storms” In this book Lilian has penned down a message to the head of state once again and believes that he will continue listening and helping those affected with cancer.
Mrs Mercy Kamau
Mercy Kamau is a Senior Palliative Care Nurse, Consultant and Trainer on health issues. She is a Kenya-registered Nurse/ Midwife. United Kingdom registered Nurse and holds a higher diploma in high dependency unit nursing. She has many years of clinical experience with the critically ill patients both in Kenya and United Kingdom.
Mercy worked as a clinical instructor at the Nairobi hospital and a senior nurse in Aga khan ICU, Manchester NHS trust U.K in the Acute cardiology ward and head of clinical department at Nairobi hospice.
She holds a higher diploma in Palliative care from Oxford Brookes University and have a BSc in palliative care from Makerere university.
Mercy is currently pursuing a Master’s degree in Palliative care specializing in children palliative care at Makerere university. She trains at Nairobi Hospice as a part time lecturer in their palliative care diploma course, affiliated to Oxford Brookes University.
Muthoni Mate
Muthoni Mate is a professional epidemiologist with over 15 years’ experience in health research and health systems strengthening within the African Continent. Her experience with end-to-end implementation of medical research programs and her aptitude for community-rooted solutions lend themselves very strongly to the type of solutions that Africa is moving towards. This involves the designing and implementing of innovative African health solutions with a global mindset.
Muthoni is a person living with Cancer and her experience crystalized the realities of lack of reliable information, under resources and a fragmented healthcare system on the outcomes of a cancer diagnosis. This redefined her world view and reaffirmed her contribution in the battle against all types of cancer which lead to the establishment of The Cancer Café (www.cancer-cafe.org) – an innovative non-profit organization that tailor- makes solutions for people living with cancer by linking them to resources and simplified, holistic, credible, consistent information about cancer prevention, management and rehabilitation.
Muthoni has been involved in the generation and implementation of key governance in cancer prevention and management -The Kenya Cancer Policy 2019-2020 and the Kenya National Cancer Control Strategy 2012 – 2020 among others.
She also seats on various technical advisory forums, The National Cancer institute of Kenya and the Non-Communicable Disease ICC Monitoring, Evaluation and Research. She is also a Rotarian – a humanitarian institution with the mission of service above self.
Sidney Misigo Chahonyo
Sidney is a confident, assertive, goal-oriented professional, with over 13 years’ experience in the public, private and social impact sectors. Sidney is an 18-year cancer survivor (cancer of the postnasal space) dedicated to changing the cancer landscape and is passionate about creating lasting social impact with regard to holistic childhood cancer care in Kenya.
He serves as the Executive Director of Hope for Cancer Kids, Kenya. He sits on the board of the Kenyan Network of Cancer Organizations (KENCO) and He is a member of the African Regional Committee of Childhood Cancer International (CCI). Sidney is a member of the technical working group for Childhood Cancer and also a member of the TWG on Prevention, Screening, & Early Detection (PSED) at the National Cancer Control Program, Kenya.
Ms Benda N. Kithaka (Moderator)
Benda Kithaka is a Health Advocacy & Behaviour Change Communications Specialist, with over 20 years’ experience in communications, research, and health advocacy.
She is the founder of KILELE Health Association, a Kenyan non-profit organization located in Nairobi, with a mandate to operate in the country’s 47 Counties.
KILELE Health specializes in empowering people living with chronic conditions (cancer and other NCDs) and their caregivers to use their lived experiences as advocacy tools for disease prevention, stigma reduction and improvement of quality of life beyond the diagnosis. The organization is committed to engaging members and other stakeholders in improving the understanding of quality of life issues. Current programmes focus on advocacy, behaviour change communications, capacity building, and exchange of best practice, research, and resourcing. This is achieved through promotion of physical activity, mental wellness, financial wellness and pursuit of optimal health; as tools for the attainment of wellbeing.
Benda sits on various global, regional and local Technical Working Groups in an advocacy and advisory role. She co-chairs the AORTIC Advocacy Special Interest Group regionally in Africa, and in Kenya is Co-Chair of the STOP Cervical Cancer technical working group. She is also a Trainer, Facilitator and Public Speaker in advocacy for Women’s Health. Previously she served on the Board of Women4Cancer for nine years, a Kenyan NGO she co-founded in 2012, whose Vision is a Cervical Cancer Free Kenya.
She has received various awards including the International Gynecologic Cancer Society (IGCS) Distinguished Advocacy Award 2019, the Union for International Cancer Control (UICC) award to participate as the civil society voice in the Regional Consultation on the Elimination of Cervical Cancer in the African Region (May 2019). She is also the Cancer Ambassador of the Year 2016 in Kenya.
An alumni of the AORTIC Master Cancer Advocacy Trainer Programme in 2013, her advocacy work includes writing the WHO Regional Office for Africa Advocacy for Cervical Cancer Prevention and Control in Africa Facilitator Manual in 2015 – 2017, and Master Training of Expert Trainers of Trainers from 10 WHO AFRO Countries in use of the toolkit in Africa (2017).
To complement her advocacy with systems strengthening, she undertook an Executive Diploma in Leading High Performing Healthcare Organisations Program (LeHHO) at the Strathmore Business School: Institute of Healthcare Management in Kenya (2016). In 2020, she was also trained as a MOTH Story Teller, a skill she is using to inspire others to tell their stories in advocacy, acting as a catalyst for change.
Under the KILELE Challenge, Benda summited Mt. Kenya Climb with Cancer Survivors in September 2020, to highlight cancer survivorship challenges and advocate for post treatment empowerment of women cancer survivors across Sub-Sahara Africa.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Ovarian Cancer
2023-05-18 19:00 - 20:30
SPEAKER PROFILES:
Dr Khadija Warfa
Khadija Warfa is a Consultant Gynecologic Oncologist, who completed her gynaecological oncology fellowship at the University of Calgary, Canada.
Currently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students.
Dr. Warfa is a member of the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya.
Dr Amina Kidee Habib
Amina K. Habib is a Medical Oncologist at the Aga Khan University Hospital, Nairobi.
She holds a Master of Medicine in Internal medicine and Fellowship in Medical Oncology from the University of Nairobi.
Dr Habib was previously the Head of the Oncology Department, Aga Khan Hospital in Mombasa where she championed multi-disciplinary approach to cancer management at the facility aimed at improving patient outcomes and organized several awareness campaign activities.
Dr. Habib has keen interest in breast cancer, GI malignancy, and translational research.
She also has a keen interest in mentorship program aimed at bridging gaps in clinical practise among young medical/clinical practitioners.
Moderator: Dr Gregory Ganda
Gregory Ganda is a renowned Gynecologist oncologist at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH). He currently runs the oncology clinic at the facility and does his private practice at various private facilities in Kisumu including but not limited to the Bloom surgical center, Aga Khan Hospital, Kisumu Specialist Hospital. He runs the gynecology oncology clinic at JOOTRH on Tuesdays and splits the rest of his time in the wards and in the theatre.
Dr Ganda is currently the County Executive Committee (CEC) Member for Health in Kisumu County (County Minister for Health)
His work as a medical officer in remote areas in Voi, where women had bad obstetric outcomes led him to start the hot tea initiative (where women who had delivered were given hot tea and baby shawls as a motivation for hospital delivery), renovation and opening of the theater which led to his special recognition and Master’s sponsorship. He went into Oncology after having met many patients with poor survival rates after lack of access to specialty care and wanted to make a difference.
His vision for the Kisumu County Cancer Alliance is to have a platform where all like-minded partners work together for the common good of the people of Kisumu to improve cancer outcomes by having an infrastructure for screening, early detection, and treatment to improve survival for cancer patients.
His hobbies involve being outdoors, traveling, hiking, and rock climbing.
Dr Ganda has a Master of Medicine in Gynecology oncology from Makerere University and a fellowship in gynecology oncology from Moi University in collaboration with the University of Toronto. He previously worked at the Coast General hospital, Ngao district hospital, and Migori county hospital.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Clinical Research in Breast Cancer
2023-05-11 18:00 - 21:00
SPEAKER PROFILES:
Dr Njoki Njiraini
Njoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital.
She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.
Dr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi, a Master’s Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.
Prof Mansoor Saleh
Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program.
His area of research and clinical focus is “targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.
Moderator: Dr Regina Nanzia
Regina Nanzia Ojiwa is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in Kenyatta National Hospital.
She holds a Bachelor’s degree in Medicine and Surgery from Moi University and a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Nanzia has key interest in Esophageal, Colorectal and Prostate cancer.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Craniopharyngiomas in Children
2023-05-04 19:00 - 20:30
SPEAKER PROFILES:
Dr Michael Magoha
Michael Magoha is a Neurological Surgeon and Lecturer at the University of Nairobi.
He is the current secretary General of the Brain Tumour Association of Kenya. He has multiple publications in Neuro-oncology, World Neurosurgery and East Africa Journal of Neurological Sciences amongst others.
Dr Magoha was part of the team instrumental in starting the first Multicentre Brain Tumour Registry in Kenya that is still ongoing.
Dr Mary S. Limbe
Mary S. Limbe is a Consultant Paediatrician and Paediatric Endocrinologist at the Aga Khan University Hospital, Nairobi.
She is Faculty on the post-graduate medical programme at the Aga Khan University, Nairobi, department of Paediatrics and child health. She is a tutor on the endocrinology Fellowship programme: Panadrica Endocrinology Training Centre for Africa (PETCA).
Dr Limbe is also actively involved in Paediatric resuscitation programmes (EPALS), as instructor, course director and trainer of trainers.
Her main areas of interest include Child Growth and Development and Type 1 Diabetes.
Dr. Bernadette Muthee – Kiigu
Bernadette Muthee-Kiigu is a Consultant Radiologist and Specialist in Pediatric Imaging at Aga Khan University,Nairobi.
She holds a Bachelor of Medicine, Bachelor of Surgery degree from the University of Nairobi and MMED Rad from Aga Khan University, Nairobi. She completed Pediatric Radiology Fellowship from The British Columbia University, BC Children’s Hospital, Canada. She is passionate about optimization of radiation protection in pediatric imaging and optimization of Pediatric MRI protocols.
Dr Bernadette is an active member of the Society for Pediatric Imaging, a corresponding member of European Society of Radiology, Member of Kenya Association of Radiologists, and member of KenyaSociety of Ultrasound in Medicine and Biology.
She is passionate about pediatric neuroimaging, and currently with ongoing work on strategies of improving and enhancing pediatric imaging in Kenya.
Moderator: Dr Beverly Cheserem
Beverly Cheserem is an Assistant Professor and Consultant Neurosurgeon at the Aga Khan University Hospital​, Nairobi​
Dr Cheserem has a sub-specialty interest in skull base surgery and pituitary, both microsurgical and endoscopic techniques. Her other interests include global health, teaching, and clinical research.
Prior to joining AKUHN, Dr Cheserem was a Weill Cornell Global Health Fellow based at Muhumbili Orthopaedic Institute, Tanzania. She has also been a Skull base Fellow, University Hospital of Wales, and Consultant Neurosurgeon, Brighton and Sussex University Hospital, UK.
In addition, Dr Cheserem has completed rotations in various University hospitals in the UK. She completed her residency in Neurosurgery in the South London Neurosurgery Rotation and obtained her Bachelors of Medicine degree with Honours from the University of Southampton, UK. Dr Cheserem has been a travelling fellow of Bellaria Hospital (Italy), Lariboisiere Hospital (France) and UPMC (USA).
She holds various international positions including:

Chair, Kenya Association of Women Surgeons (2021-23)
Vice-Chair, Scientific Committee, Surgical Society of Kenya (2021-23)
Vice-Chair, Global Surgery Committee, Surgical Society of Kenya (2021-23)​

She is a member of the following organisations:

Fellow Royal College of Surgeons, England (FRCS, Eng)
Member, Association of Medical Educators (AOME) UK
Member, British Association of Surgical Oncology (BASO)
Full Member, Society of British Neurosurgeons (SBNS), UK,
Member, Congress of Neurological Surgeons (CNS)
Member, Kenya Medical Association (KMA).
Member, Kenya Society of Haematology and Oncology (KESHO)

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

ER+ and HER2 -ve Breast Cancer
2023-04-27 19:00 - 20:30
SPEAKER PROFILES:
Dr Amina Kidee Habib
Amina K. Habib is a medical oncologist at the Aga Khan University Hospital, Nairobi.
She holds a master of medicine in Internal medicine and Fellowship in Medical Oncology from the University of Nairobi.
Dr Habib was previously the Head of the Oncology Department, Aga Khan Hospital in Mombasa where she championed multi-disciplinary approach to cancer management at the facility aimed at improving patient outcomes and organized several awareness campaign activities.
Dr. Habib has keen interest in breast cancer, GI malignancy, and translational research.
She also has a keen interest in mentorship program aimed at bridging gaps in clinical practise among young medical/clinical practitioners.
Moderator: Dr Gasambi Mwanjala
Gasambi Mwanjala is a Clinical Oncologist at the Moi County Referral Hospital, Voi.
He holds a Master’s Degree in Clinical Oncology from Muhimbili University.
His interests are in brain, head, and neck cancers.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management of Prostate Cancer
2023-04-20 19:00 - 20:30
SPEAKER PROFILES:
Dr Melissa A. Reimers
Melissa Reimers is an Assistant Professor Department of Medicine, Oncology Division, Medical Oncology at Washington University, St. Louis.
Dr Melissa holds a Bachelor’s in Medicine from the Saint Louis University School of Medicine. She did her Internal Medicine Residency at University of North Carolina, Chapel Hill, NC and her Hematology/Oncology Fellowship at University of Michigan, Ann Arbor, MI
Her clinical interests include Bladder, Kidney, and Prostate cancer.
Dr Melissa’s research interests are Clinical trial development, Phase 1 clinical trials and Precision medicine.
She is a member of the following professional societies:

Alpha Omega Alpha Honor Medical Society
American Society of Clinical Oncology (ASCO)
Academic Women’s Network at WUSM

Dr Alfred Odhiambo
Alfred Odhiambo is a Lecturer at the University of Nairobi and the Chief Radiologist at The Nairobi Hospital. He is also a radiologist at Plaza MRI Ltd.
Dr Odhiambo is an active member of the Prostate Cancer Kenya Chapter.
Dr Abeid M. Athman Omar (Moderator)
Abeid Omar is a Consultant Clinical (medical and radiation) Oncologist and Nuclear Medicine at the Kenyatta University Teaching Research and Referral Hospital (KUTRRH). He also consults for International Cancer Institute – ICI Eldoret, Kenya.
He has keen interest in breast cancer in young women, oncofertility, breast cancer research, radiotherapy, advocacy and Global Oncology particularly in LMIC.
Dr. Abeid completed his training in Clinical Oncology and Nuclear Medicine in Alexandria University Egypt in 2021. He is a fellow of College of European School of Oncology (ESCO) and he has also successfully passed the ESMO exam to become a certified ESMO oncologist.
Dr. Abeid has conducted researches, presented abstracts in ESMO, ASCO, ESTRO, St. Gallen, KESHO conferences and Aga Khan Symposium, published in peer reviewed journals about breast cancer in young women, pregnancy associated breast cancer, pregnancy after breast cancer among others under the close guidance of Prof. Hatem Azim, who has been mentoring him since 2019.
Dr. Abeid is an active member of several societies including KESHO – where he also serves as a member of the education committee, ASCO, ESMO, ESCO, Society of Toxicology. In 2019 he was awarded the ASCO Virtual Mentorship Program and currently he is under the mentorship of College of European School of Oncology. Besides, Dr. Abeid serves as a reviewer for several journals.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Esophageal Cancer
2023-04-13 19:00 - 20:30
SPEAKER PROFILES:
Dr Sitna Ali Mwanzi
Sitna Mwanzi is a Consultant Medical Oncologist at Kenyatta National Hospital with research interests in breast, lung cancer and CML.
Dr Helena Musau
Helena Musau is a Consultant Clinical Oncologist working at Kenyatta University Teaching Research and Referral Hospital.
She is also an Adjunct Lecturer at the University of Nairobi, Radiation Oncology program. Dr. Musau is a Member of various Ministry of Health technical working groups aimed at improving access to cancer care in Kenya.
She has worked in both the private and public sectors as well as managed oncology and palliative care projects at various levels over the last 13 years.
Moderator: Dr Brian Misoi
Brian Misoi is a General Surgeon with an interest in Gastrointestinal Surgery, Minimally Invasive Surgery and Surgical Oncology. He is currently a Clinical Instructor at the Aga Khan University Hospital Nairobi.
He holds a Master of Medicine in General Surgery from the Aga Khan University Hospital Nairobi, with his undergraduate training from the University of Nairobi.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Mantle Cell Lymphoma
2023-03-30 19:00 - 20:30
SPEAKER PROFILES:
Dr Beatrice Jepngetich Melly
Beatrice Melly is a Clinical Haematologist at Moi Teaching & Referral Hospital.
She holds a Bachelor’s Degree in Medicine and Surgery from Moi University and a Master’s Degree in Clinical Haematology from Alexandria University, Egypt.
Dr Melly is also the Section Head for Haematology at the Haemato Oncology Directorate at Moi Teaching and Referral Hospital.
She has over 8 years’ experience in treatment of both benign and malignant Haematological conditions.
Moderator: Dr Douglas Nyandika
Douglas Nyandika currently works at The Nairobi Hospital as a Senior registrar in Internal Medicine.
He holds a Bachelor’s Degree and Master’s in Internal Medicine from the University of Nairobi.
Dr Nyandika is currently a fellow in Medical Oncology at the University of Nairobi.
His current interests are in both hematologic malignancies especially lymphomas and leukaemia’s. In the area of solid tumours, he is interested in cancers of the breast, GI cancers and lung cancers with integration of novel therapies in their management.
He is fascinated by African writers like Chimamanda Ngozi, Akwaeke Emezi and Jennifer Nansubuga. Inspired by spiritual books by Paulo Coelho, Michael Singer, and Eckhart Tolle.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Multiple Myeloma
2023-03-16 19:00 - 20:30
SPEAKER PROFILES:
Dr Angela McLigeyo
Angela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi, a M.Sc. in Clinical Oncology from Ulm University (Germany), and a Fellowship in Medical Oncology from the University of Nairobi. In addition, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings.
She is a member of the Kenya Society of Haematology and Oncology (KESHO), European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East, Central and Southern Africa College of Physicians.
Her core skills are in clinical decision making in internal medicine and oncology, conducting trainings, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols.
Dr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities, conducts research in oncology and internal medicine when opportunities arise, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.
Dr Rohini Radia
Rohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005.
During her haematology training and work as a consultant, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation, including 10 years at consultant level at The Russell Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023, she returned home and started as BMT Consultant at the The Nairobi West Hospital.
Her BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol, GVHD prophylaxis and post-transplant management of immune suppression, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials.
Moderator: Dr Grace Kiraka
Grace Kiraka is a consultant clinical pathologist working at the M P Shah hospital.
She has a master’s in clinical pathology [Mmed Clin Path] from the Aga Khan University Hospital Nairobi and specializes in the diagnosis of blood and bone marrow disorders. Dr Kiraka has a keen interest in therapeutic apheresis and has been carrying out red cell exchange transfusions for patients living with Sickle Cell Disease at the M P Shah hospital. She hopes this therapy will soon be available to all patients with SCD that need it across the country.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Metastatic Colon Cancer
2023-03-09 18:30 - 21:00
SPEAKER PROFILES:
Dr Karan Gandhi
Karan R. K. Gandhi is a Consultant General and Hepatobiliary Surgeon at the Department of Surgery, Aga Khan University Hospital, Nairobi.
Dr. Gandhi graduated from The University of Nairobi to receive his medical degree in 2009 and did a year of internship at the Aga Khan University Hospital, Nairobi (AKUH,N) in 2010. He began his surgical training at the University of Nairobi in 2011 and then moved to the University of Cape Town in 2013. He qualified as a Fellow of the College of Surgeons of South Africa in 2018 and then went on to complete his subspecialist certificate training in Surgical Gastroenterology, specifically Hepato-Pancreatico-Biliary (HPB) Surgery, in 2020. He also received a Masters degree in Surgery (MMed) from the University of Cape Town in 2020. In the same year, Dr. Gandhi was also selected to represent Sub-Saharan Africa (SSA) in the IHPBA 2020 International Fellows Retreat in Melbourne, Australia. His main clinical interests lie in Hepatic, Pancreatic and Biliary surgery, as well as gastrointestinal surgery, advanced endoscopy, ERCP and laparoscopy. Within the realm of HPB surgery, his primary focus has been on one of the most neglected diseases in the region, namely hepatocellular carcinoma (HCC). In the Global Surgery 2030 document published by The Lancet Commission in 2015, eastern, western and central SSA were identified as the regions in the world with the greatest unmet needs in surgical care and in a strange coincidence, these are also the regions in SSA with the highest HCC incidence.
Dr. Gandhi has recently joined the AKUH,N as a full-time faculty member in the department of General Surgery, with a view to pioneering and developing HPB Surgery in Kenya, East Africa and SSA as a whole. He sees himself as one of a new generation of HPB surgeons that have a vision of changing the situation in SSA, where delivering a surgical service is hampered by a poorly managed and funded healthcare system, cost of treatment and a shortage of healthcare professionals. With the connections made during his training and the vision and guidance of his mentors, Dr. Gandhi looks forward to creating a network of young HPB surgeons to facilitate this important endeavour. He has helped set up and is currently involved in various multi-disciplinary team (MDT) meetings, including a monthly Sub-Saharan HCC meeting and an international collaborative HCC meeting with Fortis Hospitals in India. He is also actively involved with the HPB service and MDT meetings at the Kenyatta National Hospital, Kenya.
Dr. Gandhi is also passionate about teaching and training of young surgeons in Kenya, especially in the fields of laparoscopy and surgical endoscopy delivery in rural areas. He is a member of the Operating Theatre Practitioners Association of Kenya (OTPAK), where training workshops are organised for surgical trainees in the Kenyan College of Surgeons of East, Central and Southern Africa (COSECSA), in order to train and empower them to perform basic laparoscopic surgical procedures in rural centres. His role as a faculty member at the AKUH,N also includes supervision and training of surgical residents, thereby promoting academia alongside clinical service delivery. He plans to set up a surgical registry database in the hospital, which will be used to generate data, audit practice and produce high-quality research that can be published in reputable peer-reviewed journals.
With his solid background, training, passion and networking, Dr. Gandhi believes he is a key player in taking HPB surgery forward on the continent of Africa.
Dr Andrew Odhiambo
Andrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.
He is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP, ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals.
Dr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness.
His key areas of sub specialization and interest include Colon cancer, Stomach cancer, Breast Cancer, Pancreatic, Liver & Bile Duct cancer, Cancer or Unknown Primary, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Skin, Lung, Kidney cancers etc. For his full profile, please visit www.drandrewodhiambo.com
Dr Manel Haj Mansour
Manel Has Mansour is a Consultant Physician and board-certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
· A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Ahmed Komen
Dr Ahmed Komen is a Clinical Radiation Oncologist. He is a fellow of College of Medicine South Africa and holds a Master of Medicine in Radiation Oncology from the University of the Witwatersrand, Johannesburg, South Africa.
Dr Komen is a consultant at Kenyatta National Hospital and a part time faculty member at Aga Khan University Hospital.
He is an active member of various multi-disciplinary tumour boards and the Kenya Society of Haematology and Oncology (KESHO).
Moderator: Dr Tracy Irura
Tracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching, Research and Referral Hospital.
She holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

International Women's Day
2023-03-02 19:00 - 20:30
SPEAKER PROFILES:
Dr Afrin Shaffi
Afrin Shaffi is a gynecologic oncologist based in Kwale county. She completed her undergraduate studies at Manipal College of Medical Sciences in Nepal and proceeded to do her postgraduate training in Obstetrics and Gynecology at Muhimbili University of Health and Allied Sciences in Tanzania.
She did her fellowship in Gynecologic Oncology at Moi University/Moi Teaching and Referral hospital, in Eldoret as well as successfully completed the International Gynecologic Cancer Society, IGCS, fellowship.
She is an active member of the Kenya Obstetrical and Gynecological Society, KOGS, the International Gynecologic Cancer Society (IGCS) and the American Society of Clinical Oncology (ASCO).
She is currently the country lead for the international Every Woman Study in Kenya in collaboration with World Ovarian Cancer Coalition and IGCS. Dr. Shaffi is a recipient of the NIH grant under the U54 mentorship program. She has headed several outreach clinics and provided free services in underserved areas of Kenya and as an ambassador for MSF to international sites like Malawi.
Her areas of interests include ovarian and cervical cancer.
Dr Jyoti Wadhwa
Jyoti Wadhwa is a Senior Director in Medical Oncology & Hemato Oncology at Medanta – Gurugram, India.
She has more than 20 years’ experience in oncology, she is specialised in solid tumours including- breast, ovary, lung, cancer of head and neck, GI tract, prostate, bone & brain tumours.
She trained at the prestigious AIIMS New Delhi for both her MD and DM training, and skilled in Oncology, Healthcare Management, Healthcare Internal Medicine, and Clinical Research.
She has also authored a book on breast cancer and has many other publications in national & international journals of repute.
She has a Commonwealth Scholarship from Imperial College School of Medicine, Hammersmith Hospital, London. Dr Jyoti Wadhwa is a member of National Academy of Medical Sciences, New Delhi, American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) ,Life Member of Indo American Cancer Association & Delhi Medical Association and a Working Committee Member of Indian Journal of Medical and Paediatric Oncology.
She is winner of various awards like Lady Willingdon Gold Medal, MMRF Travel Grant by the Multiple Myeloma Research Foundation, USA, CSIR Full Travel Grant by Council for Scientific & Industrial Research new Delhi, to name a few.
Dr Jyoti is an author and compassionate clinician.
Moderator: Dr Khadija Warfa
Khadija Warfa is a Consultant Gynecologic Oncologist, who completed her gynaecological oncology fellowship at the University of Calgary, Canada.
Currently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students.
Dr. Warfa is a member of the Kenya Society of Haematology and Oncology (KESHO) and the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

International Childhood Cancer Day - Wilm's Tumour
2023-02-16 19:00 - 20:30
SPEAKER PROFILES:
Dr Irene Nzamu
Irene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital.
Dr Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital.
She is passionate about offering evidence based, affordable care for children with cancer & blood diseases in our resource limited settings.
Dr Francisca Munyalo
Francisca Syovata Munyalo is a Paediatric Surgeon at the Kenyatta National Hospital.
Dr Munyalo attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi.
She is passionate about surgical oncology and neonatal surgery and is involved in surgical outreaches with the aim of building the capacity of Paediatric Surgery in Kenya.
Moderator: Dr Catherine Muendo
Catherine Muendo is a Paediatric Hematologist and Oncologist who completed her fellowship training at Makerere university in collaboration with Mulago National Referral Hospital, Baylor college of medicine and Texas cancer children’s hospital.
She works as a consultant paediatrician at Kenyatta National Hospital. Dr Muendo received her medical degree (MBChB) and pediatrics and child health degree (MMed) at the University of Nairobi.
She is enthusiastic about improving the outcomes of children with blood and cancer disorders in Kenya through novel interventions that are sustainable in a resource limited setting.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Lung Cancer
2023-02-09 19:00 - 20:30
SPEAKER PROFILES:
Dr Naftali Busakhala
Naftali Busakhala is a Senior Lecturer and specialist Physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.
Dr Busakhala is also a Senior Research Fellow at the Institute of Prevention and Research, Lyon France. He has published widely in peer reviewed journals.
He holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA.
He trained in Pharmacology and Therapeutics at the Makerere University.
Dr Kevin Makori
Kevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC), Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI, under the mentorship of his PI and Director, Prof Chite Asirwa.
He also heads the Education and Training Office at the Institute, and is involved in teaching and coordination of various oncology capacity building activities.
Dr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO), a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is also a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme.
Dr Makori is a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team.
His key professional interests are in radiation sciences, immuno-oncology, clinical trials and oncology education.
He received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences, a program domiciled at Tanzania’s national oncology referral centre, Ocean Road Cancer Institute, Dar es Salaam.
Prof Mohsen Mokhtar
Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.
Prof Mokhtar is the Managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.
Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.
Dr Ahmed Magdy
Ahmed Magdy is an Assistant Professor of Medical Oncology and Hematology in the National Cancer Institute, Cairo University and currently holding the position of Vice Chair of Medical Oncology department in Baheya Cancer Center and Chair of Career Development and Fellowship program in the International Association for the Study of Lung Cancer (IASLC).
He started his career in 2006 as a resident of Medical Oncology and Hematology in the National Cancer Institute where he achieved his Master’s degree in 2009. In 2011, he completed his clinical fellowship in hematology from Princess Margaret Hospital, Toronto University, Canada followed in 2012 by 2nd Masters Degree from Ulm University, Ulm, Germany. In 2015 Dr Magdy obtained his PhD.
He held the position of Head of Medical Oncology Department in Shefa El Orman Hospital, Luxor from 2017 to 2020, then went on to become the Medical Director from 2020 till 2021.
Dr Magdy has published more than 17 articles and case presentations, reviewer in peer reviewed journals, in addition to being a speaker in many conferences both nationally and internationally. His main area of focus is Lung cancer, breast cancer and malignant hematology.
Moderator: Dr Manel Haj Mansour
Manel Haj Mansour is a Consultant Physician and board certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017. She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
·A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of KESHO, ESMO, ASCO, STOM (Tunisian Society of Medical Oncology). Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management/Updates in Treatment of Early Cervical Cancer
2023-01-26 19:00 - 20:30
SPEAKER PROFILES:
Dr Catherine Nyongesa
Catherine Nyongesa is a Clinical and Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital, with over 20 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi), Master of Medicine in Radiation Oncology (University of the Witwatersrand, South Africa), and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa.
Among the key organizations, she has been a member of the American Society of Clinical Oncology (ASCO), Health Professions Council of South Africa, International Gynecologic Cancer Society, and is former Chair of the Kenya Society of Haematology and Oncology (KESHO).
She has received a number of awards in recognition of her work nationally and globally. These include:

Conquer Cancer Foundation (2011, ASCO Annual Meeting),
IDEA (International Development Education Award- ASCO, 2009)
IGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008
Employee excellence award KNH 2007,
MMED dissertation paper passed with distinction 2005 at University of the Witwatersrand, SA.
Best O level and A level student Misikhu Girls High school (St Cecilia)

Dr Catherine Nyongesa is the first female radiation oncologist in Kenya.
She is one of the founders of the Texas Cancer Center Nairobi, and currently holds the position of Head of Department of the Cancer Treatment Centre at Kenyatta National Hospital. She is an Honorary Lecturer at the University of Nairobi and the Project/Program Leader of the American Cancer Society (ACS) Patient Navigation Program at Kenyatta National Hospital. She is also the Regional Project Coordinator for the following International Atomic Energy Agency (IAEA)Project: AFRA- RAF/6/055 on Improving the Quality of Radiotherapy in the Treatment of Frequently Occurring Cancers.
Dr Peter Itsura
Peter Itsura is an Obstetrician/Gynaecologist and Gynaecologic Oncologist. He works in the Department of Reproductive Health at Moi University School of Medicine, College of Health Sciences. He is a Lecturer and Acting Chair of Department. He teaches and offer clinical services at the Moi Teaching and Referral Hospital.
Dr Itsura is the current deputy Chair, Division of Gynaecologic Oncology and deputy lead AMPATH Cervical Cancer Prevention Program (ACCP) with screening clinics spread throughout the AMPATH Catchment are in Western Kenya.
He started the first Clinical Fellowship at Moi University in collaboration with his colleague and other North American partners from the University of Toronto. This was not only the first such training in Kenya but indeed in the region.
Moderator: Dr Jackline Makokha
Jackline Makokha is Clinical Oncologist at Jaramogi Oginga Odinga Teaching and Referral Hospital and Synergy Clinics in Kisumu.
She holds an MBCHB from University of Nairobi and MPH degree from the University of Liverpool (UK) from where her thesis work on Triple Negative Breast cancer led her to pursue a Masters in Clinical Oncology and Nuclear Medicine from Alexandria University (Egypt).
Her interests are in Breast, Prostate, Cervical and Colorectal cancer.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

PROSTATE CANCER PRECEPTORSHIP PROGRAMME in Conjunction with Cairo University
2022-12-09 19:00 - 20:30
SPEAKER PROFILES:
Prof Mohamed Abdallah
Mohamed is the Head of Clinical Oncology department at Kasr Al- Aini Center of Oncology and Nuclear Medicine (NEMROCK), Cairo University.
Dr. Mohamed has a special interest and expertise in management of colorectal cancer, advanced head and neck cancers, musculoskeletal cancers and genito-urinary cancers.
Dr Primus Ochieng
Primus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital.
He has keen interest in head and neck and prostate cancer treatment. Dr. Ochieng is committed to ensure the program produces well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this, he is keen in collaborating with various centers in the developed world in areas of training, research and skill development.
Prof Alaa Meshref
Alaa Meshref is a Consultant Urologist in multiple institutes and transplant surgeon on Cairo Kidney Center.
He has vast experience in prostate cancer diagnosis with over 20,000 prostate biopsies performed and recently adding cognitive fusion with mpMRI of the prostate across large patient-base patients with BPH and prostate cancer in various stages of the disease.
Prof. Alaa has given more than 20 teaching courses about transrectal ultrasound and prostatic biopsies in conferences and universities. He has presented more than 300 lectures about the early detection of prostate cancer and management of different disease stages
Dr Samuel N. K. Waweru
Samuel Waweru is a Consulting Urologist at the Nairobi Hospital, Mater Hospital among others. He is formerly the chair, Department of Surgery at the Mater Hospital.
Dr Waweru holds a Master’s from the University of Nairobi, urology training from KCMC Moshi, Tanzania.
His interests are in prostatic cancer and urolithiasis.
Moderator: Dr Tracy Irura
Tracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching, Research and Referral Hospital.
She holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Breast cancer preceptorship programme in Conjunction with Cairo University
2022-12-08 19:00 - 20:30
SPEAKER PROFILES:
Dr Gladwell Kiarie
Gladwell Kiarie graduated with MBChB (Bachelor of Medicine and Bachelor of Surgery) degrees from The University of Nairobi and went head to receive her post-graduate degree in Internal Medicine from the same institution. After receiving her undergraduate degrees, she did her internship at the Kenyatta National Hospital before proceeding to pursue her fellowship in Medical Oncology in London, England.
After sub-specialization in Medical Oncology, she returned to Kenya where she was one of the founding members of the Oncology Unit at the Aga Khan University Hospital and was also part of the team that set up the first Kenyatta National Hospital Tumor Board in 2007 that involved multiple personnel from surgical and medical departments.
She then joined the University of Nairobi in the Clinical Medicine Department as a Senior Lecturer. Soon afterwards, she enrolled in a PhD program with the Bart’s Cancer Institute under the supervision of Professor John Gribben. She recently received Fellowship to the Royal College of Physicians of Edinburgh (FRCPE).
Dr Kiarie currently runs a private practice at The Nairobi Hospital and also reviews patients at other leading hospitals in Nairobi and Nakuru including The Aga Khan University Hospital, MP Shah Hospital, and Avenue Hospital. She also serves in the Kenya Medical Practitioners and Dentists Board since her appointment in 2015 to the Regulatory Department of the Board.
She is a member of the Kenya Society of Haematology and Oncology (KESHO) where she also served as the treasurer in 2004 and is also a full member of the American Society of Clinical Oncology (ASCO) as well as European Society for Medical Oncology (ESMO).
She continues to be an advocate for early diagnosis of cancer and is greatly involved in programs that focus on providing easy access to basic screening services to the under privileged including setting up oncology services at the county level. In recognition of this, she won the Union for International Cancer Control (UICC) in 2014 for screening in poor settings.
Dr Catherine Nyongesa Watta
Catherine Nyongesa is a Clinical and Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital, with over 20 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi), Master of Medicine in Radiation Oncology (University of the Witwatersrand, South Africa), and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa.
Among the key organizations, she has been a member of the American Society of Clinical Oncology (ASCO), Health Professions Council of South Africa, International Gynecologic Cancer Society, and is former Chair of the Kenya Society of Haematology and Oncology (KESHO).
She has received a number of awards in recognition of her work nationally and globally. These include:

Conquer Cancer Foundation (2011, ASCO Annual Meeting),
IDEA (International Development Education Award- ASCO, 2009)
IGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008
Employee excellence award KNH 2007,
MMED dissertation paper passed with distinction 2005 at University of the Witwatersrand, SA.
Best O level and A level student Misikhu Girls High school (St Cecilia)

Dr Catherine Nyongesa is the first female radiation oncologist in Kenya.
She is one of the founders of the Texas Cancer Center Nairobi, and currently holds the position of Head of Department of the Cancer Treatment Centre at Kenyatta National Hospital. She is an Honorary Lecturer at the University of Nairobi and the Project/Program Leader of the American Cancer Society (ACS) Patient Navigation Program at Kenyatta National Hospital. She is also the Regional Project Coordinator for the following International Atomic Energy Agency (IAEA)Project: AFRA- RAF/6/055 on Improving the Quality of Radiotherapy in the Treatment of Frequently Occurring Cancers.
Prof Mohsen Mokhtar
Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.
Prof Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.
Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.
Dr Loay Kassem
Loay Kassem is an Assistant Professor of Clinical Oncology at Cairo University in Egypt.
He had earned his medical degree from Kasr El Eini Medical School – Cairo University in 2005 and MD in Clinical Oncology from Cairo University in 2016.
Dr Kassem is a Research Fellow in Center Léon Bérard, Lyon, France. He participated as a Co-investigator in several international clinical trials and has authored several scientific papers in international journals.
Moderator: Dr Thomas Odeny
Thomas Odeny is a Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute and also holds a joint appointment as Assistant Professor of Medicine in the Division of Oncology at the Washington University in St. Louis, USA. He is Board Certified in Internal Medicine by the American Board of Internal Medicine and completed his Medical Oncology Fellowship at the US National Cancer Institute/National Institutes of Health.
He holds an MPH and PhD in Epidemiology from the University of Washington in Seattle, USA. He is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), American Association for Cancer Research (AACR), and the International AIDS Society.
He has authored more than 30 peer-reviewed scientific manuscripts. His research has been published in scientific journals such as ‘Journal of ImmunoTherapy of Cancer’, ‘Lancet HIV’, ‘PLOS Medicine’, ‘BMC Medicine’, ‘Implementation Science’, ‘Clinical Infectious Diseases’, ‘Journal of Acquired Immune Deficiency Syndromes’, and ‘Journal of the International AIDS Society’ among others. In recognition of his contribution to research and clinical care, he has received multiple awards including ‘Conquer Cancer Global Oncology Young Investigator Award’, ‘American Society of Clinical Oncology Merit Award’, ‘Sirridge Award for Outstanding Humanistic Qualities – University of Missouri’, ‘Conference on Retroviruses and Opportunistic Infections Young Investigator Award’, and was the first recipient of the ‘Kenya National AIDS Control Council Young Investigator Award’, Kenya’s highest award for young scientists in HIV.
His career vision in Global Oncology is to address gaps in cancer care by translating research advances to practical and scalable cancer programs in low-resource settings in the U.S. and in Africa through high-quality direct patient care and clinical/translational and implementation research.
His clinical research interest is broadly focused on reducing disparities in eligibility for immunotherapy clinical trials and expanding treatment options for cancer in people living with HIV. He is studying the effect of CD4+ T cell count on treatment-emergent adverse events and survival among patients with and without HIV receiving immunotherapy for advanced cancer. This work led to an ASCO Merit Award (2021).
As an ASCO Global Oncology Young Investigator Awardee, Dr. Odeny is also studying the association between Kaposi sarcoma-associated herpesvirus (KSHV) subtypes and clinical severity of disease in patients with KSHV-associated diseases (KAD) in North America and Africa. This will be among the first studies to evaluate KSHV subtype and cytokine profiles as predictors of survival in patients with KAD such as Kaposi sarcoma, primary effusion lymphoma, and KSHV-associated multicentric Castleman disease. By integrating patient clinical characteristics with KSHV genomic analyses, this study will provide a platform for understanding diseases that disproportionately affect low-income, stigmatized, and marginalized communities globally, and are therefore understudied to date.
He is also interested in leading patient and clinician education initiatives in global oncology with plans to establish a formal program in Global Oncology between KEMRI and Washington University in St. Louis. This will be a platform for training of a new generation of globally-oriented physicians who will advance scientific discovery for underserved populations with cancer globally. This will be an important step toward sustaining the potential spread of emerging cancer prevention and therapeutic strategies globally and make a lasting impact.
Prior to pivoting to a career in Global Oncology, Dr. Odeny was in-country PI or co- investigator for multiple NIH-funded trials, including 3 NIH R01s. These trials studied the application of implementation science to promote engagement in the HIV care cascade, and the use of technological innovations to support HIV prevention and treatment efforts. There is a growing recognition that urgent research is needed to find optimal approaches for the translation of efficacious clinical interventions into effective and appropriately scaled programs in the global response to cancer and HIV. As such, Dr. Odeny is interested in leveraging his expertise in implementation science to the growing academic field of global oncology.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

The 7th Kenya International Cancer Conference
2022-11-24 - 2022-11-26 | Sarova Whiteands Hotel, Mombasa
Theme: Improving Cancer Outcomes: Innovations, Opportunities & Strategies in the Care Continuum

Every 2 years, at the Kenya International Cancer Conference (KICC), the Kenya Society of Haematology and Oncology (KESHO) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policymakers and support staff to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients.
For the first time KESHO held a hybrid conference. The physical event was held at Sarova Whitesands Hotel, Mombasa. The presentations focused on Improving Cancer Outcomes: Innovations, Opportunities & Strategies in the Care Continuum. The conference saw the highest number of abstracts submitted, partnerships, media coverage and most delegates.
The conference also featured two pre-conference workshops Radiation Oncology Contouring and Planning Workshop and Colorectal Surgery Preceptorship workshop. The cancer burden can only be realised by strengthening health systems. The speakers highlighted work done on policy, implementation and strategies of multisector and multilevel measures aimed at ensuring efficient and effective delivery of preventative, diagnostic, treatment and palliative care services to our patients.
There was a collaborative session with King’s College London (KCL) where the speakers shared research findings of a comprehensive analysis of cancer research outputs in Africa -what does this means for Kenya?
The conference saw over 400 attendees from countries across the world including: Kenya, Uganda, Tanzania, Burundi, Egypt, Somaliland, Zambia, Malawi, India, Lesotho, South Africa, USA, Canada, Botswana, Sudan and Ethiopia.
View all abstracts

Loading Viewer...

Loading Viewer...

Loading Viewer...

https://www.flickr.com/photos/197046194@N04/albums

Management of Metastatic Non-Small Cell Lung Cancer
2022-11-03 19:00 - 20:30
SPEAKER PROFILES:
Dr Omar Abdihamid
Omar Abdihamid is a Clinical Oncologist at Garissa Cancer Center and HCGCCK Cancer Centre.
He holds a Master’s degree in Clinical Oncology from Central South University, China.
His main areas of interest are Esophageal cancers, Head and Neck cancers, Lung cancer, Genitourinary cancers and Breast cancers.
Dr Omar is passionate about cancer care equity in low- and middle-income countries and advocates for culturally based cancer care. He has a keen interest in Cancer research and has published multiple publications in international peer-reviewed journals.
He is also an a scientific writer, editor and a reviewer for several cancer journals.
Dr Omar is the recipient of the “2021 Journal of Clinical Oncology, ASCO Global Oncology Trainee Journal Reviewer Mentoring Program” and the winner of “Africa ASCO VOICES 2022”– for highlighting state of cancer care in Kenya.
He is a member of:

Kenya Society of Haematology and Oncology (KESHO)
African Organization for Research and Training in Cancer (AORTIC)
European Society of Medical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)

Finally, Dr. Omar is a resident faculty member and tumour board panelist at the International Cancer Institute in Eldoret, Kenya.
Moderator: Dr Helena Musau
Helena Musau is a Consultant Clinical Oncologist working at Kenyatta University Teaching Research and Referral Hospital.
She is also an Adjunct Lecturer at the University of Nairobi, Radiation Oncology program. Dr. Musau is a Member of various Ministry of Health technical working groups aimed at improving access to cancer care in Kenya.
Dr Musau has worked in both the private and public sectors as well as managed oncology and palliative care projects at various levels over the last 13 years.

Hormonal Therapy in Breast Cancer
2022-10-27 19:00 - 20:30
SPEAKER PROFILES:
Dr Manel Haj Mansour
Manel Haj Mansour is a consultant physician and board certified medical oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
· A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Kevin Makori
Kevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC), Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI, under the mentorship of his PI and Director, Prof Chite Asirwa.
He also heads the Education and Training Office at the Institute, and is involved in teaching and coordination of various oncology capacity building activities.
Dr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO), a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme.
He is a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team.
His key professional interests are in radiation sciences, immuno-oncology, clinical trials and oncology education.
He received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences, a program domiciled at Tanzania’s national oncology referral centre, Ocean Road Cancer Institute, Dar es Salaam.
Moderator: Dr Hilda Mubisi
Hilda Mubisi is a Clinical Oncologist based at the Kakamega Teaching and Referral Hospital.
She holds a Bachelor’s of Medicine and Surgery from Moi University and a Masters in clinical Oncology and nuclear medicine from Alexandria University – Egypt.
Dr Mubisi has interest in breast, colon and gynecological cancers.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Optimizing Treatment Outcomes for HR+ and HER2-ve Metastatic Breast Cancer
2022-10-20 19:00 - 20:30
SPEAKER PROFILES:
Dr Amina Kidee
Amina Kidee is a Medical Oncologist at the Aga Khan University Hospital, Mombasa.
Her interests are in breast cancer, GI malignancy, and translational research.
Prof Olivia Pagani
Olivia Pagani was responsible, at the Institute of Oncology of Southern Switzerland (IOSI), for breast cancer medical treatment and clinical research from 2005 to 2019 and of the Clinic for cancer predisposition and high-risk individuals from 2002 to 2019. From 2013 to 2018 she was director of the IOSI Eusoma and Swiss certified Breast Unit and from 2005 to 2008 co-president of the SAKK (Swiss Group for Cancer Research) breast cancer project group.
She is the current coordinator of the breast cancer programme of the European School of Oncology and breast cancer consultant at Hopital Riviera-Chablais, Rennaz, Vaud.
In April 2017 she was nominated Full Professor at the Medical School University of Geneva and in 2019 Full Professor at the Medical School University of Lugano.
Her main research interests in the last years have been breast cancer in young women and advanced breast cancer.
She is panel member of the ESO-ESMO Advanced Breast Cancer (ABC) and chair of the ESO-ESMO Breast Cancer in Young Women Consensus Conferences (BCY). She has been panel member of the San Gallen International Consensus Conference for Early Breast cancer in 2017 and 2019.
Moderator: Dr Siwillis Mithe
Siwillis Mithe is a clinical radiation oncologist at the Nakuru County Teaching and Referral Hospital with particular interest in breast, pediatric, head and neck and neuro-oncology. She has been key in instituting multidisciplinary meetings within the hospital, problem-oriented research in the department and streamlining patient care within oncology clinics.
She holds a Masters of Medicine in Clinical Oncology and is extensively trained in radiation therapy and chemotherapy for a variety of cancers.
Dr Siwillis has interest in research having attended and presented papers at both local and international conferences and also has a number of publications to her name. She has played a key role in the roll out of National Cancer Screening and Treatment guidelines and has been very instrumental in raising cancer awareness across the country. She is an advocate of quality and affordable cancer care for all patients.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Genetic Testing For Breast Cancer
2022-10-13 19:00 - 20:30
SPEAKER PROFILES:
Dr Mohammed Ezzi
MBCHB, MMed, FMOnC (UoN)
Mohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society.
He did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology.
His academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge amongst non-oncologist. He has presented at several symposia, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP. His key areas of interest include breast cancer, malignant hematology and clinical pharmacology.
Dr Catherine Mutinda
MD, M.MED Pediatrics & Child Health, MSc. Medical Genetics & Genomics, DIP. SRHR
Catherine Mutinda serves as a pediatrician within the Nairobi City County and the National Secretary to the Kenya Pediatrics Association board. She received her medical degree from 1st faculty of Medicine, Charles University Prague, the Czech Republic, a Masters of Medicine in Pediatrics and Child Health from the University of Nairobi, and a Master of Science in Medical genetics and genomics from the University of Glasgow, Scotland.
Dr Mutinda has been involved in several operational researches in child health practice. She was involved in setting up the Kangaroo Mother Care and breastmilk bank under one roof at the Pumwani Maternity Hospital, helping the hospital attain the prerequisites a baby- friendly hospital as envisioned by the WHO. She is a reviewer/committee member at the Scientific and Ethics Review Unit – KEMRI. She committed to growing the practice of genetics in Kenya.
Moderator: Dr Naomi Nyambura Kimani
Naomi Kimani is a Clinical Oncologist and Radiation Specialist at Kerugoya County Referral Hospital Cancer Center.
She holds a Bachelor`s degree in Medicine and Surgery from Moi University and Master`s degree in Clinical Oncology from Alexandria University, Egypt.
She is a member of Kenya Society of Haematology and Oncology (KESHO), African Organization for Research and Training in Cancer (AORTIC), and ASCO.
Her main interests are in management of breast cancer, gastrointestinal malignancies, palliative care and radiotherapy.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management of Early Breast Cancer
2022-10-06 08:00 - 17:00
SPEAKER PROFILES:
Dr Miriam Mutebi
Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers.
She is the President Elect of the African Organization for Research and Training in Cancer (AORTIC), the Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union folr International Cancer Control (UICC). She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons.
She is the Co-chair of the National Cancer Taskforce in Kenya, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with three Lancet commissions of Women and cancer, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot’s licence in order to extend breast care services to marginalised areas.
Dr Ahmed Komen
Ahmed Komen is a Clinical Radiation Oncologist. He is a fellow of College of Medicine South Africa and holds a Master of Medicine in Radiation Oncology from the University of the Witwatersrand, Johannesburg, South Africa.
He is a Consultant at Kenyatta National Hospital and a part time faculty member at Aga Khan University Hospital.
Dr. Komen is an active member of various multi-disciplinary tumour boards and the Kenya Society of Haematology and Oncology (KESHO).
Moderator: Dr Mwongeli Matheka
Mwongeli Matheka is a General Surgeon at Eldoret Regional Hospital.
She earned her MBChB from the University of Nairobi and Master of Medicine in General Surgery from Aga Khan University.
Dr Matheka has a special interest in breast surgical oncology and improving access to surgical care in the region.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Breast Cancer Policy in Kenya
2022-10-04 19:00 - 20:30
SPEAKER PROFILES:
Dr Mary Nyangasi
Mary Nyangasi is a medical doctor and global health physician with a 17-year career experience in medical practice, clinical and preventive oncology, cancer policy formulation and programming at the Ministry of Health in Kenya. She currently serves as the Head of the National Cancer Control Program and Co-Chair of the National Cancer Taskforce.
She is passionate about improving access to care across the cancer care continuum and health system strengthening to ensure delivery of services in a timely, safe and effective manner. She has led the formulation and implementation of various cancer policy documents and guidelines including the Breast Cancer Screening and Early Diagnosis Action Plan 2021-2025. Globally, she has also contributed to the drafting of the Global Strategy for Elimination of Cervical Cancer abd the Global Breast Health Initiative. She has interest in cancer research especially in the area of preventive oncology and behavioural studies and have published a number of papers in various peer-reviewed journals.
Dr Nyangasi is a member of the Kenya Medical Association, the Africa Cancer Coalition, the Kenya Red Cross and the Kenya Society of Haematology and Oncology.
Dr Daniel Ojuka
Daniel Ojuka is a Lecturer & Oncoplastic Breast and Endocrine Surgeon, University of Nairobi & Kenyatta National Hospital.
He holds a Bachelor of Medicine and Surgery from the University of Nairobi and Masters of Medicine in Surgery from the same institution.
Dr Ojuka is the current President of the Surgical Society of Kenya.
Moderator: Dr Naftali Busakhala
Naftali Busakhala is a senior lecturer and specialist physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.
Dr Busakhala is a senior research fellow at the Institute of Prevention and Research, Lyon France. He has published widely in peer reviewed journals.
He holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA.
He trained in Pharmacology and Therapeutics at the Makerere University.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

CML - Choosing the Next Treatment
2022-09-22 19:00 - 20:30
SPEAKER PROFILES:
Dr Charles A. Schiffer, MD
Charles A. Schiffer, MD, is Professor of Medicine and Oncology at Wayne State University School of Medicine and the Karmanos Cancer Institute in Detroit, Michigan. He is the director of the Leukemia/Lymphoma Multidisciplinary Program.
Dr. Schiffer earned his BA cum laude at Brandeis University and his M.D. at New York University School of Medicine. He completed his internship, residency, and chief residency in Internal Medicine at Bellevue Hospital under the auspices of New York University School of Medicine and had subsequent training and positions at the Baltimore Cancer Research Institute, National Cancer Institute and the University of Maryland School of Medicine, where he served as Chief of the Division of Hematology. He has also served as Chief of the Division of Hematology/Oncology and Director of Clinical Research at the Karmanos Cancer Institute.
Dr. Schiffer has authored and co-authored more than 300 articles and 80 book chapters on topics concerning the treatment of leukemia in adults, platelet transfusion, and granulocyte transfusion therapy, among others. He has served on the Editorial Boards for Blood, the Journal of Clinical Oncology, International Journal of Hematology, Transfusion Medicine Reviews and Transfusion, and reviews articles for multiple journals. Committee memberships have included Chairman of the Leukemia Committee of the Cancer and Leukemia Group B, Chairman of the Food and Drug Administration Oncologic Drug Advisory Committee, and grant reviews for the NCI and Leukemia/Lymphoma Society of America. Dr. Schiffer has been named among American Health Magazine’s and Castle Connelly’s “Best Doctors in America,” “Best Cancer Specialists in the US.” In 2006, he received the Dr. John J. Kenney Award from the Leukemia/Lymphoma Society of America and the Celgene Award for Career Achievement in Hematology. He has received multiple teaching awards from Wayne State University and was recently inducted into the Academy of Scholars, the highest recognition accorded to academic faculty at the University.
Dr Matilda Ong’ondi
Matilda Ong’ondi is a Consultant Physician and Clinical Hemato-Oncologist at the Kenyatta National Teaching and Referral Hospital, Kenya’s oldest and largest hospital. She holds a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree (2005) and a Master of Medicine (MMed) degree in Internal Medicine (2010), both from the University of Nairobi. She is registered with the Kenya Medical Practitioners and Dentists Council as an Internal Medicine Specialist.
Dr. Matilda pursued her Clinical Hemato-oncology training at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Australia in 2017. In addition, she has undertaken various short Fellowship opportunities through the following institutions: International Chronic Myeloid Leukemia Foundation (Royal Adelaide Hospital and SAHMRI Adelaide, 2017); American Society of Hematology, Visitor Training Program at The Cancer Therapy and Research Centre, San Antonio Texas (2014); and Mayo Clinic, Rochester, Minnesota (2010).
Her main interests are: Multiple Myeloma; Acute Leukemia; Chronic Leukemia; and Platelet disorders. Her other interests are Psycho-Oncology and Clinical Research. She is also passionate about clinical bedside teaching and mentorship.
Dr. Matilda is a member of various societies: Kenya Society of Hematologists and Oncologists (KESHO); European Hematology Association (EHA); and International Society of Thrombosis and Hemostasis (ISTH). In addition, she served as a member of the bodies that developed the Kenya National Cancer Guidelines and NCCN Harmonized Guidelines.
Moderator: Dr Angela McLigeyo
Angela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi, a M.Sc. in Clinical Oncology from Ulm University (Germany), and a Fellowship in Medical Oncology from the University of Nairobi. In addition, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings.
She is a member of the Kenya Society of Haematology and Oncology (KESHO), European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East, Central and Southern Africa College of Physicians.
Her core skills are in clinical decision making in internal medicine and oncology, conducting trainings, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols.
Dr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities, conducts research in oncology and internal medicine when opportunities arise, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Prostate Cancer
2022-09-15 19:45 - 20:45
SPEAKER PROFILES:
Prof Mack Roach
Professor Mack Roach III, MD, is a Professor of Radiation Oncology, Medical Oncology and Urology, at the University of California, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 10 years, his research efforts have been directed at defining optimal imaging modalities, as well as criteria for defining target volumes and improved treatment techniques.
Prof Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology.
Prof Roach is a member of several professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, Radiation Therapy Oncology Group, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU), the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials).
Prof Silke Gillessen
Professor Silke Gillessen is a Medical Oncologist with focus on genitourinary cancer.
She completed her training in Basel, St. Gallen, and the Dana Farber Cancer Institute, Boston. After returning to Switzerland, she built up the medical oncology unit for genitourinary cancer and headed the clinical research unit for oncology/haematology in Cantonal Hospital, St Gallen.
She served for two terms as president of the SAKK GU group, she chaired the EORTC Genitourinary Cancers Group, and has founded the Advanced Prostate Cancer Consensus Conference (APCCC).
Since 2018, Prof Gillessen has been Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester and Honorary Consultant at The Christie Hospital, while continuing to work as Consultant in the Department of Oncology/Haematology at the Kantonsspital St. Gallen, Switzerland.
In January 2020 Prof Gillessen was appointed Head of the Department of Medical Oncology, full professor at the Università della Svizzera Italiana (USI) in Lugano and Director of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona, Switzerland.
Dr Samuel Nguku
Dr Samuel Nguku is a Consultant in Radiology and Nuclear Medicine at Aga Khan University Hospital Nairobi.
He has a master’s degree in Radiology from Aga Khan University and fellowship in Nuclear medicine from Imperial College London.
Dr Nguku was integral in setting up of the first PET CT service in Kenya at the Aga Khan University Hospital Nairobi.
He has great passion in improving cancer imaging in the country and integrating molecular imaging in management of cancer patients.
Moderator: Dr Angela Waweru
Dr Angela Waweru is a Consultant Clinical Oncologist and Section Head of Radiation Oncology at Aga Khan University Hospital, Nairobi.
She graduated from the University of Sheffield and undertook her Core Medical and Clinical Oncology training in Sheffield Teaching Hospitals NHS Trust where she received her certificate of completion of training in 2015 and thereafter took on a Consultant Clinical Oncologist position within the same trust.
She is passionate about increased uptake of advanced radiation technological advances that achieve better outcomes and less toxicity. She has been instrumental at starting advanced radiation services at a leading health care facility in Nairobi. She has also promoted public private partnerships within radiation oncology and in 2022 started a pathway for treating patients requiring more conformal techniques of treatment not readily available at their institutions.
Dr Waweru is keen on promoting radiotherapy governance, she has started radiotherapy safety committees, peer review meetings and service development projects that benchmark local activities against standard guidelines.
She is a Fellow of the Royal College of Radiologist (Clinical Oncology faculty), Member of the Royal College of Physicians and Kenya Society of Haematology and Oncology.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Childhood Cancer
2022-09-08 19:00 - 20:30
SPEAKER PROFILES:
Dr, S. P. Yadav
Dr Yadav is currently working as the Director of Pediatric Hemato Oncology & Bone Marrow Transplant at Medanta Hospital Gurugram India. He holds a Bachelor of Medicine and Surgery from University College of Medical Sciences. He has a Diploma in Child Health from Maulana Azad Medical College, D.N.B (Pediatrics) from Sir Ganga Ram Hospital, Delhi. Fellow in Pediatric Hemato-Oncology, Royal Alexander Hospital for Children, Westmead Australia
His clinical focus is primarily Pediatric Leukemia and Bone Marrow transplantation. He has a goal to make BMT available and affordable to all those who need it. With a rich experience of more than 24 years he has performed over 400 blood & marrow transplants including 50 unrelated donor/cord transplant and 50 Haplo identical bone marrow transplants.
Dr Yadav is an accomplished editor on Oncopedia, and has worked on the editorial front for cure4kids, St. Jude’s Hospital USA, he has also been endowed with ANZCCSG scholarship and he presented a paper during SIOP meeting in Brisbane. He successfully worked as the national co-coordinator on National Training Program in Practical Pediatric Hematology (NTPPPH), and as a secretary for Organ Transplant Group, Indian Academy of Pediatrics. He was awarded with the prestigious Dr CK Bhalla Award in the year 2002
His areas of interest include pediatric leukemia, pediatric blood disorders, pediatric oncology, and blood & marrow transplantation.
Dr Yadav is a member of:
· American Society of Hematology (ASH)
· American Society of Clinical Oncology (ASCO)
· International Society of Pediatric Oncology (SIOP)
· Pediatric Hemato-Oncology (PHO)
· Chapter of Indian Academy of Pediatrics (IAP)
Dr Yadav has published widely in national and international journals.
Dr Deborah Omeddo
Dr. Deborah Omeddo is a Paediatric Haematologist and Oncologist working in Kisii Teaching and Referral Hospital.
She holds a Master’s in Paediatrics and Child Health from the University of Nairobi. She did her fellowship training at Makerere University.
Dr Omeddo strives to provide quality health services to children living with cancer and blood diseases. Her vision is that all children in Kenya will have access to quality healthcare services regardless of location and socio-economic status.
Moderator: Dr Irene Nzamu
Dr Irene Nzamu is a Pediatric Hematologist Oncologist and Head, Pediatric Hemato Oncology Unit, Kenyatta National Hospital.
She completed her undergraduate training (MBChB) and postgraduate training (M.MED) at University of Nairobi. She did her Fellowship in Pediatric Hematology and Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital.
Dr Nzamu is passionate about offering evidence based, affordable care for children with cancer & blood diseases in our resource limited settings.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Conducting Cancer Clinical Trials In East Africa Are We Ready?
2022-09-01 19:00 - 20:30
SPEAKER PROFILES:
Professor Mansoor Saleh
Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program.
His area of research and clinical focus is “targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.
Moderator: Dr Sitna Mwanzi
Sitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany.
Her research interests include breast cancer, lung cancer, prostate cancer, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer, role of screening, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal
